Skip to main content
Journal cover image

Inhibiting the inhibitor: targeting vascular endothelial protein tyrosine phosphatase to promote tumor vascular maturation.

Publication ,  Journal Article
Kontos, CD; Willett, CG
Published in: J Natl Cancer Inst
August 21, 2013

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Cancer Inst

DOI

EISSN

1460-2105

Publication Date

August 21, 2013

Volume

105

Issue

16

Start / End Page

1163 / 1165

Location

United States

Related Subject Headings

  • Zebrafish Proteins
  • Receptor-Like Protein Tyrosine Phosphatases, Class 3
  • Receptor, TIE-2
  • Oncology & Carcinogenesis
  • Neovascularization, Pathologic
  • Lung Neoplasms
  • Female
  • Enzyme Inhibitors
  • Breast Neoplasms
  • Antineoplastic Agents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kontos, C. D., & Willett, C. G. (2013). Inhibiting the inhibitor: targeting vascular endothelial protein tyrosine phosphatase to promote tumor vascular maturation. J Natl Cancer Inst, 105(16), 1163–1165. https://doi.org/10.1093/jnci/djt199
Kontos, Christopher D., and Christopher G. Willett. “Inhibiting the inhibitor: targeting vascular endothelial protein tyrosine phosphatase to promote tumor vascular maturation.J Natl Cancer Inst 105, no. 16 (August 21, 2013): 1163–65. https://doi.org/10.1093/jnci/djt199.
Kontos, Christopher D., and Christopher G. Willett. “Inhibiting the inhibitor: targeting vascular endothelial protein tyrosine phosphatase to promote tumor vascular maturation.J Natl Cancer Inst, vol. 105, no. 16, Aug. 2013, pp. 1163–65. Pubmed, doi:10.1093/jnci/djt199.
Journal cover image

Published In

J Natl Cancer Inst

DOI

EISSN

1460-2105

Publication Date

August 21, 2013

Volume

105

Issue

16

Start / End Page

1163 / 1165

Location

United States

Related Subject Headings

  • Zebrafish Proteins
  • Receptor-Like Protein Tyrosine Phosphatases, Class 3
  • Receptor, TIE-2
  • Oncology & Carcinogenesis
  • Neovascularization, Pathologic
  • Lung Neoplasms
  • Female
  • Enzyme Inhibitors
  • Breast Neoplasms
  • Antineoplastic Agents